3 days ago · CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer.

Find the latest CERo Therapeutics Holdings, Inc. (CERO) stock quote, history, news and other vital information to help you with your stock trading and investing.

4 days ago · Get the latest CERo Therapeutics Holdings, Inc. (CERO) stock price with financials, statistics, dividends, charts and more.

Get CERo Therapeutics Holdings Inc (CERO:OTCQB) real-time stock quotes, news, price and financial information from CNBC.

3 days ago · CERO's current price target is $45.00. Learn why top analysts are making this stock forecast for CERo Therapeutics at MarketBeat.

CERo, incorporated in Delaware on September 23, 2016, and based in South San Francisco, focuses on genetically engineering immune cells to fight cancer. Since inception, CERo has developed its …

3 days ago · Get the latest CERo Therapeutics Holdings, Inc CERO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Dec 26, 2025 · CERo Therapeutics Holdings Inc is an immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer.

CERo Therapeutics Holdings Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CERO stock price.

A high-level overview of CERo Therapeutics Holdings, Inc. (CERO) stock. View (CERO) real-time stock price, chart, news, analysis, analyst reviews and more.